Hypoxia promotes genetic instability and is therefore an important factor in carcinogenesis. We have previously shown that activation of the hypoxia responsive transcription factor HIFα can enhance the mutagenic phenotype induced by the environmental mutagen benzo[a]pyrene (BaP). To further elucidate the mechanism behind the ability of hypoxia to increase mutagenicity of carcinogens, we examined the activation and detoxification of BaP under hypoxic conditions. To this end, the human lung carcinoma cell line A549 was treated with BaP under 20%, 5% or 0.2% oxygen for 18 h and alterations in BaP metabolism were assayed. First, BaP-induced expression of key metabolic enzymes was analysed; expression levels of the activating CYP1A1 and CYP1B1 were increased, while the detoxifying enzymes UGT1A6 and UGT2B7 were significantly reduced by hypoxia. To evaluate whether these changes had an effect on metabolism, levels of BaP and several of its metabolites were determined. Cells under hypoxia have a reduced capacity to metabolise BaP leaving more of the parent molecule intact. Additionally, BaP-7,8-dihydrodiol, the pre-cursor metabolite of the reactive metabolite BaP-7,8-dihydroxy-9,10-epoxide (BPDE), was formed in higher concentrations. Finally, under hypoxia, DNA adducts accumulated over a period of 168 h, whereas adducts were efficiently removed in 20% oxygen conditions. The delayed detoxification kinetics resulted in a 1.5-fold increase in DNA adducts. These data indicate that the metabolism under hypoxic conditions has shifted towards increased activation of BaP instead of detoxification and support the idea that modulation of carcinogen metabolism is an important additional mechanism for the observed HIF1 mediated genetic instability.
Introduction
Although hypoxia plays an important role in normal development and physiology, disruption of oxygen homeostasis is an important characteristic of a number of pathologies including cancer (1) and chronic inflammation (2) . Therefore, understanding the mechanisms by which cells respond to hypoxia can be of etiological as well as therapeutic interest. We previously demonstrated that hypoxia inducible factor α (HIFα) stabilisation augmented benzo[a]pyrene (BaP) induced DNA adduct levels and subsequent mutation frequencies. These data indicated that concurrent exposure of hypoxia and exogenous genotoxins could enhance genetic instability (3) . For example, in pathologies in which oxygen intake is decreased such as COPD, changed carcinogen metabolism could explain the increased cancer risk observed in these patients (4) .
HIFα is regarded as the primary molecular switch to alter gene expression in response to reduced oxygen tension. Hydroxyl groups are attached to HIFα, via an oxygen-dependent prolyl hydroxylase (5). The hydroxylated HIFα is then targeted for ubiquitylation (6) and subsequent proteasomal degradation (7) . Under hypoxic conditions, HIFα becomes stabilised and translocated into the nucleus, where it forms a heterodimer with the aryl hydrocarbon receptor nuclear translocator (ARNT) (8) . Subsequently, the HIF-1 heterodimer binds to hypoxic responsive elements (9) and induces the expression of a wide array of genes able to augment oxygen delivery or provide alternative pathways for energy production and cell metabolism (10) .
As hypoxia is a common characteristic of many tumors and because HIFα can also be induced by aberrant oncogenic activation or loss of tumor suppressor function, HIFα is often found overexpressed in many cancers (11, 12) . HIFα overexpression and its downstream effectors are associated with increased tumor invasion and metastasis, resistance to chemo-, radio-and immunotherapy, and increased mortality (8, 11, 13) . In addition, exposure of cultured cells to hypoxia results in an elevated mutation frequency (14, 15) . Several mechanisms have been proposed for this observation including downregulation of DNA repair (16) , induction of reactive oxygen species mediated DNA generated during reoxygenation (17) , and competition for ARNT (3) .
In addition to forming heterodimers with HIFα, ARNT also dimerizes with the aryl hydrocarbon receptor (AhR). AhR is a receptor for environmental pollutants such polycyclic aromatic hydrocarbons (PAH), which are widely distributed environmental contaminants produced as byproducts of combustion processes as in vehicle exhaust and cigarette smoking. BaP is a classic example of PAH and is readily absorbed by inhalation, ingestion and through the skin. Given the lipophilic behaviour of BaP, it can easily diffuse into cells, where it can bind AhR. Upon binding, AhR translocates together with its ligand into the nucleus, dimerizes with ARNT, and binds to xenobiotic response elements of target genes (18) . This results in the transcription of genes that encode for enzymes involved in xenobiotic detoxification, including the cytochrome P450 (CYPs) isoforms CYP1A1 and CYP1B1 (19, 20) .
The detoxification of BaP is a multistep process involving a number of critical enzymes. The first stage requires an epoxidation reaction by the mono-oxygenases CYP1A1 and CYP1B1 (phase I) that requires NADPH and molecular oxygen. One of the resulting metabolites (e.g. BaP-7,8-epoxide) can be converted to a dihydrodiol (e.g. BaP-7,8-diOH) by epoxide hydrolase. BaP-7,8-dihydrodiols can be further metabolised by CYP1A1 or CYP1B1 to diol epoxides [e.g. BaP-7,8-diol-9,10-epoxide (BPDE)] or conjugated by uridine diphosphate glucuronosyl transferase (UGT) (phase II) (20) . BPDE is the active mutagenic compound as it can covalently bind to DNA to form pro-mutagenic adducts (19) .
We recently demonstrated that under normal oxygen conditions chemical stabilisation of HIFα augmented BaP induced adduct levels. Furthermore, we observed a marked increase in adduct levels under hypoxic exposure (3) . Interestingly, as the metabolism of BaP is oxygen dependent, exposure of cells to low oxygen concentrations was expected to generate less bioactive BaP metabolites, which in turn would lead to reduced BPDE-DNA adduct levels. To further elucidate the mechanism behind the ability of hypoxia to increase mutagenicity of carcinogens, alterations in metabolism and adduct kinetics were determined. In this current report, we show that hypoxia alters the pro-mutagenic capacity of BaP by increasing the formation of BaP-7,8-dihydrodiol (BaP-7,8-diOH), the precursor of BPDE and prolonging the exposure to the parent BaP compound, which results in an increased BPDE-DNA adducts.
Materials and methods
Cell culture and treatment A549 cells (human epithelial lung carcinoma cells), obtained from the American Tissue Culture Collection (ATCC, Rockville, MD, USA), were cultured in DMEM (Sigma, St. Louis, MO, USA) supplemented with 10% heat inactivated fetal calf serum (FCS, Invitrogen, Breda, The Netherlands) and 1% penicillin/streptomycin (Sigma) and maintained at 37°C in a 5% CO 2 atmosphere. Cells were seeded 1 day before treatment and maintained at 37°C in a 5% CO 2 atmosphere and different oxygen concentrations (20%: normal culture conditions, 5%: physiologically relevant oxygen levels or 0.2%: hypoxic conditions). All cells were treated with 0 or 0.1 µM BaP (Sigma) dissolved in DMSO (final DMSO concentrations did not exceed 0.5%). Experiments have been performed in triplicate. After treatment, medium was removed and cells were harvested using trypsin. All samples were stored at −20°C.
Real-time quantitative PCR
Cells were washed twice with PBS followed by Qiazol (Qiagen, Hilden, Germany) addition. Total RNA was isolated according to the manufacturer's instructions. The RNA samples were quantified spectrophotometrically using a Nanodrop 1000 (Thermo Scientific, Waltham, MA, USA). cDNA synthesis was performed using the iScript cDNA Synthesis kit (Biorad, Veenendaal, The Netherlands) starting with 1 µg of RNA. cDNA was diluted 25× in RNase free water. Real-time PCR was performed using the MyiQ Single Color RT-PCR detection system (Biorad) using SYBR Sensimix Sybr Green (Quantace, London, UK), 5 µl diluted cDNA and 0.3 µM primers (Table I ) in a total volume of 25 µl. Samples were amplified under the following conditions: 95°C for 3 min, followed by 40 cycles of 95°C for 15 s and 60°C for 45 s. PCR was checked for aspecific products by performing a melting curve analysis (65-95°C). Data were analysed using the MyiQ Software system (Biorad) and were expressed as relative gene expression (fold increase) using the 2 -∆ ∆ C t method. The stably expressed gene cyclophilin A was included as reference.
DNA isolation
Cells were harvested and resuspended in 400 μl SET/SDS (100 mM NaCl, 20 mM EDTA, 50 mM Tris, 0.5% SDS) and incubated at 37°C for 2 h. Fifty microlitres of DNAse-free RNAse-solution [RNAse A (0.1 mg/ml) and RNAse T1 (1000 U/ml) in SET, incubated at 80°C for 5 min] was added and samples were incubated at 37°C for 1 h followed by addition of 50 μl DNAse-free proteinase K (10 mg/ml in SET-SDS, pre-incubated at 37°C for 30 min) and samples were incubated overnight at 37°C. After addition of 500 μl phenol/ chloroform/isoamyl alcohol (25:24:1), samples were rotated for 5 min and centrifuged for 5 min at 14 000 rpm. To the upper aqueous phase, 500 μl chloroform/isoamyl alcohol (24:1) was added and samples were rotated for 5 min, centrifuged for 5 min (14 000 rpm) and 1/30 volume NaAc (3M, pH 5.2) was added to the upper phase. Samples were mixed for a few seconds and two volumes ethanol 100% (4°C) were added, samples were mixed and incubated at −20°C for 30 min. Samples were centrifuged for 5 min and DNA pellets were washed with ethanol 70%. DNA pellets were dried and resuspended in Mili-Q H 2 O. The quantity of the DNA was measured using the Nanodrop 1000.
32 P-postlabeling of BPDE-DNA adducts DNA adduct levels were determined according to the nuclease P1 enrichment technique originally described by Reddy and Randerath (21) with the modifications described by Godschalk et al. (22) . In all experiments, three BPDE-DNA standards with known BPDE-DNA adduct levels (one adduct per 10 6 , 10 7 and 10 8 normal nucleotides) were analysed in parallel for quantification purposes. Adducts spots in DNA from BaP treated A549 cells that chromatographed at the same position as the BPDE-DNA adducts standards were considered to be derived from BPDE, and were quantified using Phosphor-Imaging technology (Fujifilm FLA-3000, Rotterdam, The Netherlands).
HPLC
In order to determine BaP-metabolite composition, 4 ml medium was extracted with 1 ml ethyl acetate after addition of 1 ml 3M NaCl. Samples were vortexed for 10 min, centrifuged for 5 min at 1000 rpm and after briefly vortexed, centrifuged again for 10 min at 1500 rpm. The ethyl acetate fraction was collected and the extraction step was repeated twice. The second time and third time, only ethyl acetate was added and the third time, also two droplets of ethanol were added to the samples for better separation. The ethyl acetate fractions were combined, evaporated to dryness under N 2 , and residues were resuspended in 0.5 ml methanol. For quantitation purposes, a standard mix consisting of 50 ng/ ml BaP-9,10-diol, 50 ng/ml BaP-7,8-diol, and 50 ng/ml BaP-3-phenol (Midwest Research Institute, Kansas City, Missouri, USA) was used. Samples were analysed on a Gynkotek P580A HPLC system (Separations Analytical Instruments, Hendrik Ido Ambacht, The Netherlands) with a Spark SP830 autosampler (Spark Holland, Emmen, The Netherlands) and a Perkin Elmer LS-30 programmable fluorescence detector (Perkin Elmer, Foster City, CA, USA). Excitation/emission wavelengths were 257/>350 nm. For quantification, the area of each metabolite peak and the BaP peak on the chromatogram was determined. In addition, the peak areas of the three metabolites were compared with average peak areas of three replicate injections of a standard mix containing all three metabolites and subsequently concentrations of the metabolites were calculated.
Statistical analysis
Results are expressed as the mean ± standard error of the mean. GraphPad Prism 4 was used for statistical analysis. To examine differences between cells incubated with or without BaP a two-way analysis of variance test (ANOVA) with Bonferroni post hoc multiple comparison correction was used. To assess differences between various oxygen concentrations a one-way ANOVA with Bonferroni post hoc multiple comparison correction was used. Area under the curve was computed using the trapezoidal method. Differences were considered to be statistically significant when P < 0.05.
Results

BaP-mediated induction of phase I enzymes CYP1A1 and CYP1B1 is increased under hypoxia
To determine whether oxygen levels affect the induction of CYP1A1 ( Figure 1A ) and CYP1B1 ( Figure 1B ) and the subsequent metabolic activation of BaP, gene expressions were determined in A549 cells treated with or without 0.1 µM BaP for 18 h at the different oxygen concentrations. Both CYP isoforms showed higher mRNA levels under hypoxic conditions. BaP induced CYP1A1 levels were ~1.3-fold higher in cells cultured under 0.2% oxygen compared to cells cultured in 20% oxygen (P < 0.05). CYP1B1 gene expression under hypoxic conditions was induced by ~1.6-fold (P < 0.001) and ~2.1-fold (P < 0.001) compared to 20% oxygen, in the absence and presence of BaP, respectively. Under 5% oxygen conditions, BaP-induced CYP1A1 mRNA levels were reduced with ~33 % (P < 0.05) compared to 20% oxygen, but CYP1B1 mRNA levels were similar. This induction of phase I enzyme expression under hypoxic conditions suggests an increased metabolic activation of BaP.
Hypoxia decreased phase II enzymes UGT1A6 and UGT2B7 gene expression
To investigate whether enzymes involved in the detoxification of BaP are altered under hypoxic conditions, gene expression was measured for the UDP glucuronosyltransferases, UGT1A6 and UGT2B7, two enzymes responsible for the conjugation of BaP metabolites and subsequent excretion of BaP. UGT1A6 gene expression was ~18% (P < 0.05) and ~37% (P < 0.001) lower for cells in 5% and 0.2% oxygen, respectively, independent of BaP treatment ( Figure 1C ). When cells were under hypoxic conditions, a statistical significant ~41% (P < 0.01) and ~35% (P < 0.05) decreased level of UGT2B7, for DMSO and BaP treated cells respectively, was observed compared to 20% oxygen ( Figure 1D ). BaP treated cells cultured in 5% oxygen showed no decrease in gene expression of UGT2B7, while the DMSO treated cells had a 33% (P < 0.05) lower gene expression compared to cells under 20% oxygen. This induction in gene expression of BaP activating enzymes and reduction of detoxifying gene expression under hypoxic conditions suggests that metabolism is directed towards an increased activation of BaP.
Higher levels of unmetabolised BaP in medium of hypoxic cells
To determine if increased CYP mRNA levels results in increased BaP metabolism, remaining unmetabolised BaP was measured extracellularly after 18 h of incubation. Incubation under 20% and 5% oxygen resulted in only 7% and 0.3%, respectively, of the original amount of BaP being left after 18 h. Importantly, extracellular BaP levels in hypoxic cells were 9-fold higher (P < 0.001) compared to cells incubated under 20% oxygen since only 35.9% of the original amount of BaP has been metabolised (Table II) . The hypoxia induced increase in BaP parent compound suggests that, although an increased CYP expression is observed, lack of oxygen prevents the metabolism of BaP under hypoxic conditions, while in the normoxic cells the BaP is conjugated.
The active metabolite BaP-7,8-diOH is enriched in cells treated with hypoxia for 18 h
To determine whether hypoxia directs the metabolism of BaP towards unfavorable activation, three important BaP metabolites, BaP-9,10-dihydrodiol (BaP-9,10-diOH), BaP-7,8-dihydrodiol (BaP-7,8-diOH) and 3-hydroxy-BaP (BaP-3-OH), were measured extracellularly ( Figure 2 and Table II) . Extracellular BaP-9,10-diOH and BaP-3-OH metabolite levels were significantly lower in hypoxic cells compared to the 20% oxygen condition, ~53%, (P < 0.01) and ~32% (P < 0.05), respectively. In hypoxic cells the amount of extracellular levels of BaP-7,8-diOH were increased ~3.7-fold (P < 0.001), compared to cells cultured under 20% oxygen. On the other hand, BaP-7,8-diOH levels were lower (~82% (P < 0.001)) in cells cultured under 5% oxygen compared to 20% oxygen. So despite reduced BaP metabolism, more BaP-7,8-diOH is observed under hypoxic conditions suggesting an increased opportunity for the formation of BPDE-DNA adducts.
BaP-mediated induction of BPDE adducts is decreased in hypoxia
Since the distribution and metabolism of BaP is affected by the different oxygen concentrations, the formation of promutagenic BaP-DNA adduct could also have changed. Therefore, BPDE-DNA adduct levels in cells treated with 0.1 µM BaP and incubated in 20%, 5% or 0.2% oxygen were measured ( Figure 3) . No difference in adduct levels were found between the cells exposed to 20% and 5% oxygen, however a statistical significant ~70% lower adduct level was observed in cells exposed to 0.2% oxygen compared to normoxic cells.
Hypoxia prolongs exposure to BaP by altering metabolism kinetics
Gene expression and metabolism results directed towards an increased formation of BPDE-DNA adduct under hypoxic conditions. However results showed a decreased formation of these adducts. Nonetheless, a well-documented and logical factor critical for carcinogenesis is the duration of BaP exposure (23) . To determine if indeed under hypoxic conditions the exposure to BaP and its metabolites was increased, a time kinetic experiment was performed to compare the regular culturing oxygen concentration with hypoxic conditions for a prolonged exposure period. Up to 32 h, similar levels of both BaP-7,8-diOH ( Figure 4A ) and BaP-3-OH ( Figure 4B ) were observed under oxygen conditions, although the metabolic rate was reduced in the cells under hypoxic conditions as there was less BaP metabolised ( Figure 4C ). The metabolites in the medium of cells cultured under 20% oxygen could be detected up to 56 h after BaP addition, while in the hypoxic cells the amount of metabolites increased further to a ~1.8-fold and ~1.5-fold higher level compared to 20% oxygen for BaP-7,8-diOH and BaP-3-OH, respectively. Under hypoxic conditions, the metabolites remained present for a significantly longer time and could be detected up to 144 h after BaP addition.
Hypoxia induced increase in BaP exposure time leads to more DNA adducts
To determine whether the hypoxia induced changes in BaP metabolism results in more adducts, BPDE-DNA adducts were measured in the time kinetic experiment. The adduct levels in cells cultured under 20% oxygen were for the first 56 h higher than under hypoxic conditions ( Figure 4D ). At 48 h, the amount of adducts was ~6.5 adducts per 10 7 nucleotides, after which the adduct levels decreased, while in the hypoxic cells the amount of adducts increased to a ~4.5 adducts per 10 7 nucleotides 96 h after BaP addition. To determine the total amount of adducts formed during the whole incubation period, the area under the 3 . Lower adduct levels under hypoxic conditions. A549 cells were treated with 0.1 µM BaP and incubated in an atmosphere containing 20%, 5% or 0.2% oxygen and BPDE-DNA adduct levels were measured. Data (n = 3) are presented as mean ± standard error and * indicate statistical significant differences compared to 20% oxygen. 1.00 ±0.12 0.30 ±0.01* 0.68 ±0.03* A549 cells were treated with 0.1 µM BaP and incubated in an atmosphere containing 20%, 5% or 0.2% oxygen for 18 h and the extracellular BaP levels and the BaP metabolites; BaP-9,10-diOH, BaP-7,8-diOH and BaP-3-OH were measured and normalised for the amount present at 20% oxygen. Data (n = 3) are presented as mean ± standard error. * indicates statistical significant difference compared to 20%.
curve was measured. Importantly, under hypoxic conditions, the amount of adducts formed was ~1.5 times higher compared to cells under cultured under 20% oxygen. These data indicate that under hypoxic conditions the BaP metabolism has shifted towards increased activation of BaP.
Discussion
The link between hypoxia and pathologies such as cancer may be the result of the previously reported increased mutation frequencies (14, 15) . Understanding the mechanisms involved in mutation induction is important in determining the role of hypoxia in genetic instability. Previously, we have shown a novel mechanism in which the interaction between induction of the HIF1 pathway and the AhR-pathway led to an increase in BaP-induced mutations (3). In this current study, we further elucidated the mechanism behind the ability of hypoxia to increase mutagenicity of carcinogens. We provide evidence that hypoxia changes carcinogen metabolism towards a more activating metabolic pattern and alters kinetics of BaPmetabolism resulting in an increase in BaP and BaP-7,8-diOH exposure and subsequent increase in BPDE-DNA adduct formation.
The induction of CYP1A1 is believed to be an activating event leading to enhanced levels of reactive metabolites and subsequent carcinogenesis. For example, a positive correlation was found between CYP1A1 activity and pulmonary PAHassociated DNA adduct formation (24) while high CYP1A1 inducibility in lymphocytes has been related to a high lung cancer risk (25, 26) . Conversely, CYP1A1 knockout mice were more susceptible to form adducts indicating the dual role of CYPs in activating and deactivating carcinogens (27) . In this study, we showed that BaP induced CYP1A1 and CYP1B1 gene expression were augmented under hypoxia compared to cells cultured under 20% oxygen (Figure 1 ). This induced expression suggests an increased conversion of BaP and a subsequent enhanced elimination by conjugation, which however depends on phase II enzymes. Therefore, we assessed the expression of UGTs as these enzymes have a profound effect in both detoxification and promotion of BaP excretion and in particular, UGT2B7 exhibited strong activity towards BaP-7,8-diOH (28) . The UGT gene expressions in this study showed lower levels under hypoxic conditions independent of the addition of BaP. The increased phase I enzymes and decreased phase II enzyme gene expression under hypoxia suggests a possible diversion of the metabolism towards the formation of BPDE. Decreased UGTs reduces the amount of BaP-7,8-diOH conjugation while at the same time the increase in CYPs may result in an increased metabolism of BaP-7,8-diOH towards BPDE.
To investigate the effect of BaP metabolic gene expression alteration, BaP metabolites were measured extracellular (Table  II) . Under hypoxic conditions, only 36% of the BaP was metabolised within 18 h of incubation, while at 5% and 20% oxygen most of the BaP, 99.7% and 93%, respectively, was metabolised after 18 h of incubation. Extracellular levels of BaP-3-OH, a non-mutagenic metabolite of BaP and BaP-9,10-diOH, precursor of BaP-9,10-diol-7,8-epoxide, which is much less carcinogenic compared to BPDE, were lower at 0.2% oxygen compared to 20% and 5% oxygen. On the other hand, levels of the BPDE precursor BaP-7,8-diOH were much higher under hypoxic conditions. The higher metabolite production under hypoxic conditions is in line with the higher expression of CYP1A1 and CYP1B1 in cells exposed to hypoxia and treated with BaP ( Figure 1) . Overall, the levels of the metabolites are much higher under hypoxic conditions while the metabolism of BaP itself is decreased.
It seems in contrast with our hypothesis that we found the lowest BPDE-DNA adduct levels under hypoxic conditions, compared to 20% and 5% oxygen conditions, for which similar adduct levels were observed (Figure 3) . It is however possible that the reduced metabolism also reduced the formation of adducts and that in fact the adduct formation still need to increase and metabolite levels still have to rise further. Therefore, incubation times of up to 168 h were used to determine the differences in the formation of BPDE-DNA adducts over a prolonged exposure period in cells cultured at regular culturing conditions and at hypoxic conditions (Figure 4 ). The BaP metabolism was reduced under hypoxic conditions, which however did not result in a decreased formation of metabolites. In fact, this reduced metabolism resulted in a prolonged formation of BaP-7,8-diOH, and BaP-3-OH metabolites and in the end, more ethyl acetate extractable metabolites were formed in the cell during the metabolism of BaP. Importantly, the alteration in metabolism resulted in a 1.5 times more DNA adducts being formed under hypoxic conditions compared to cells cultured in 20% oxygen. This correlates well with the study by Ross et al. (23) in which a relation between the total amount of adducts present in time and tumor induction in mouse lung was observed and concluded that area under the curve is a better predictor of cancer risk than peak adducts levels. This suggests that in BaP exposure studies, the timing of kinetics must be carefully considered. Our data indicate that the observed induced CYP gene expression under hypoxic conditions does not increase BaP metabolism, but rather the metabolism of BaP-7,8-diOH to BPDE. This in combination with a reduced detoxification of BaP-7,8-diOH results in an increased formation of BPDE-DNA adducts. In addition, under 20% oxygen conditions, BaP-7,8-diOH was absent after 56 h and DNA adducts were below the limit of detection after 96 h. Under hypoxic conditions BaP-7,8-diOH was almost completely absent after 120 h while after 168 h DNA adducts were still present. This suggests that also nucleotide excision repair could be affected as we have previously shown that preventing the breakdown of HIF decreases the nucleotide excision repair capacity (3, 29) .
The prolonged presence of adducts under hypoxic conditions could result in a greater genetic instability. That our in vitro findings can be translated to the in vivo situation is exemplified by results obtained in skin exposed Ahr (−/−) mice that showed a lower metabolic clearance of BaP resulting in increased formation of BaP-7,8-diOH metabolites, and higher levels of unmetabolised BaP and DNA adduct levels in tissues, especially lung. So, in intact animals hypoxic interference of the Ahr signaling pathway is very well anticipated to lead to similar effects upon exposure to BaP (30) .
Taken together, these results suggest that cells exposed to low oxygen concentrations generate more bioactive BaP metabolites. Although we did not determine whether the effects are HIF dependent, our previous reports suggest that differences in BaP metabolism are a result of the effects on the HIF pathway (3, 29) . Importantly, we demonstrate that the time in which cells were exposed to BaP was elongated under hypoxic conditions. This ultimately led to prolonged time to form BPDE-DNA adducts in the cells, which is associated with increased tumorigenesis. Interestingly, this suggests that pathologies that limit the oxygen tension such as COPD or local hypoxia due to e.g. inflammation or poor angiogenesis can result in a disturbed oxygen balance and a subsequent dysregulation of the carcinogen detoxification and increased cancer risk.
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